MAPT and neurodegenerative disease: Clinical studies corroborated by epidemiological evidence in neurodegenerative diseases have suggested a role that sex may play in modulating the release of tau, a neuroaxonal injury marker, into biofluids while interacting with disease development and progression (10–12).